Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Intra-Cellular Therapies, Inc. | Financial_Report.xls |
| 10-K - FORM 10-K - Intra-Cellular Therapies, Inc. | d675342d10k.htm |
| EX-31.2 - EX-31.2 - Intra-Cellular Therapies, Inc. | d675342dex312.htm |
| EX-31.1 - EX-31.1 - Intra-Cellular Therapies, Inc. | d675342dex311.htm |
| EX-10.8 - EX-10.8 - Intra-Cellular Therapies, Inc. | d675342dex108.htm |
| EX-10.19 - EX-10.19 - Intra-Cellular Therapies, Inc. | d675342dex1019.htm |
| EX-32.1 - EX-32.1 - Intra-Cellular Therapies, Inc. | d675342dex321.htm |
| EX-10.14 - EX-10.14 - Intra-Cellular Therapies, Inc. | d675342dex1014.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-193310) pertaining to the ITI, Inc. 2003 Equity Incentive Plan, as amended, and the Intra-Cellular Therapies, Inc. 2013 Equity Incentive Plan of our report dated March 25, 2014 with respect to the financial statements of Intra-Cellular Therapies, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2013.
/s/ Ernst & Young LLP
McLean, VA
March 25, 2014